"Diabetes Mellitus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Descriptor ID |
D003920
|
MeSH Number(s) |
C18.452.394.750 C19.246
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus".
This graph shows the total number of publications written about "Diabetes Mellitus" by people in this website by year, and whether "Diabetes Mellitus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 2 | 2 | 4 |
2002 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2004 | 0 | 2 | 2 |
2005 | 2 | 0 | 2 |
2006 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2009 | 4 | 1 | 5 |
2010 | 1 | 0 | 1 |
2011 | 8 | 1 | 9 |
2012 | 4 | 0 | 4 |
2013 | 4 | 1 | 5 |
2014 | 5 | 2 | 7 |
2015 | 8 | 1 | 9 |
2016 | 15 | 8 | 23 |
2017 | 210 | 81 | 291 |
2018 | 198 | 80 | 278 |
2019 | 73 | 23 | 96 |
2020 | 162 | 60 | 222 |
2021 | 69 | 51 | 120 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Mellitus" by people in Profiles.
-
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? Blood Coagul Fibrinolysis. 2021 Dec 01; 32(8):544-549.
-
Utilisation of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare? Intern Med J. 2021 12; 51(12):2021-2026.
-
Response to Letter to the Editor From Woolcott and Castilla-Bancayán: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults". J Clin Endocrinol Metab. 2021 11 19; 106(12):e5277-e5278.
-
Letter to the Editor From Woolcott and Castilla-Bancayán: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults: Age and Diabetes in COVID-19 Severity". J Clin Endocrinol Metab. 2021 11 19; 106(12):e5273-e5274.
-
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief Bioinform. 2021 11 05; 22(6).
-
Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019. Cardiol Rev. 2021 Nov-Dec 01; 29(6):292-295.
-
[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status]. Nutr Hosp. 2021 Oct 13; 38(5):1068-1074.
-
Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States. JAMA Intern Med. 2021 10 01; 181(10):1412-1414.
-
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic. Expert Rev Proteomics. 2021 08; 18(8):707-717.
-
A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update. BMC Infect Dis. 2021 Sep 03; 21(1):906.